Cardlytics, Inc.
US ˙ NasdaqGM ˙ US14161W1053

Introduction

This page provides a comprehensive analysis of the known insider trading history of Amit Gupta. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Amit Gupta has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CDLX / Cardlytics, Inc. Chief Executive Officer, Director 491,759
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Amit Gupta. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CDLX / Cardlytics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CDLX / Cardlytics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CDLX / Cardlytics, Inc. Insider Trades
Insider Sales CDLX / Cardlytics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CDLX / Cardlytics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-19 CDLX Gupta Amit 68,685 1.1180 68,685 1.1180 76,790 15 0.8899 -15,666 -20.40
2025-08-18 CDLX Gupta Amit 68,260 1.1250 68,260 1.1250 76,792
2025-07-02 CDLX Gupta Amit 6,725 1.7826 6,725 1.7826 11,988
2025-04-02 CDLX Gupta Amit 7,342 1.8060 7,342 1.8060 13,260
2025-02-19 CDLX Gupta Amit 54,565 3.1790 54,565 3.1790 173,462
2025-02-18 CDLX Gupta Amit 46,857 3.3980 46,857 3.3980 159,220
2025-01-24 CDLX Gupta Amit 15,160 3.9200 15,160 3.9200 59,427
2025-01-03 CDLX Gupta Amit 5,964 3.6670 5,964 3.6670 21,870
2024-10-24 CDLX Gupta Amit 22,607 3.8450 22,607 3.8450 86,924
2024-10-02 CDLX Gupta Amit 7,543 3.0850 7,543 3.0850 23,270
2024-07-24 CDLX Gupta Amit 22,699 8.6650 22,699 8.6650 196,687
2024-07-02 CDLX Gupta Amit 7,507 7.9530 7,507 7.9530 59,703
2024-04-24 CDLX Gupta Amit 23,416 11.9100 23,416 11.9100 278,885
2024-01-24 CDLX Gupta Amit 72,658 6.1010 72,658 6.1010 443,286

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CDLX / Cardlytics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Amit Gupta as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-19 2025-08-19 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -68,685 491,759 -12.26 1.12 -76,790 549,787
2025-08-19 2025-08-18 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -68,260 560,444 -10.86 1.12 -76,792 630,500
2025-08-19 2025-08-18 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 125,000 628,704 24.82
2025-08-19 2025-08-18 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 125,000 628,704 24.82
2025-07-02 2025-07-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -6,725 378,704 -1.74 1.78 -11,988 675,078
2025-07-02 2025-07-01 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 14,349 385,429 3.87
2025-04-03 2025-04-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -7,342 371,080 -1.94 1.81 -13,260 670,170
2025-04-03 2025-04-01 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 14,350 378,422 3.94
2025-02-19 2025-02-19 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -54,565 364,072 -13.03 3.18 -173,462 1,157,385
2025-02-19 2025-02-18 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -46,857 418,637 -10.07 3.40 -159,220 1,422,529
2025-02-19 2025-02-16 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 125,000 465,494 36.71
2025-02-19 2025-02-16 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 125,000 465,494 36.71
2025-01-24 2025-01-24 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -15,160 215,494 -6.57 3.92 -59,427 844,736
2025-01-24 2025-01-23 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 43,750 230,654 23.41
2025-01-06 2025-01-03 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -5,964 186,904 -3.09 3.67 -21,870 685,377
2025-01-06 2025-01-01 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 14,349 192,868 8.04
2024-10-24 2024-10-24 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -22,607 178,519 -11.24 3.84 -86,924 686,406
2024-10-24 2024-10-23 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 43,750 201,126 27.80
2024-10-03 2024-10-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -7,543 157,376 -4.57 3.08 -23,270 485,505
2024-10-03 2024-10-01 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 14,350 164,919 9.53
2024-07-24 2024-07-24 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -22,699 150,569 -13.10 8.66 -196,687 1,304,680
2024-07-24 2024-07-23 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 43,750 173,268 33.78
2024-07-02 2024-07-02 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -7,507 129,518 -5.48 7.95 -59,703 1,030,057
2024-07-02 2024-07-01 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 14,349 137,025 11.70
2024-04-24 2024-04-24 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -23,416 122,676 -16.03 11.91 -278,885 1,461,071
2024-04-24 2024-04-23 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 43,750 146,092 42.75
2024-01-24 2024-01-24 4 CDLX Cardlytics, Inc.
Common Stock
S - Sale -72,658 102,342 -41.52 6.10 -443,286 624,389
2024-01-24 2024-01-23 4 CDLX Cardlytics, Inc.
Common Stock
M - Exercise 175,000 175,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)